Inadequate growth hormone suppression following an octreotide test dose predicts the need for adjuvant therapy to achieve 'safe' growth hormone levels.


Autoria(s): Lindsay, John
Data(s)

01/04/2006

Identificador

http://pure.qub.ac.uk/portal/en/publications/inadequate-growth-hormone-suppression-following-an-octreotide-test-dose-predicts-the-need-for-adjuvant-therapy-to-achieve-safe-growth-hormone-levels(b28c45bb-b514-49b3-b7e4-57a9e2118d85).html

http://dx.doi.org/10.1111/j.1365-2265.2006.02480.x

http://www.scopus.com/inward/record.url?scp=33644905284&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Lindsay , J 2006 , ' Inadequate growth hormone suppression following an octreotide test dose predicts the need for adjuvant therapy to achieve 'safe' growth hormone levels. ' Clinical Endocrinology , vol 64(4) , no. 4 , pp. 475-476 . DOI: 10.1111/j.1365-2265.2006.02480.x

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1310 #Endocrinology
Tipo

article